The ReWalk ReStore

What is the ReWalk ReStore™?

The ReWalk ReStore is a powered, lightweight soft exo-suit intended for use in the rehabilitation of persons with lower limb disability due to stroke. It will be a first of its kind gait training solution.

 

Who is it for?

ReStore is designed to be used in a clinic setting for the rehabilitation of persons with lower limb disability due to stroke. There are an estimated 3 million stroke survivors with gait impairments in the United States alone.

 

How does it work?

The device is designed to perform ambulatory functions in rehabilitation institutions under the supervision of a trained therapist for people with hemiplegia/ hemiparesis due to stroke. The device is not intended for sports or stair climbing. It provides coordinated plantarflexion and dorsiflexion assistance to a patient’s impaired side. Power is transmitted through cables to attachment points on a calf wrap and a shoe insert.

Using a handheld smartphone controller, a trained therapist is able to monitor key metrics and adjust assistance level, as well as record standard gait training assessments and compare sessions.

 

What makes ReStore different?

The ReStore is designed to be a versatile, cost effective gait therapy solution which offers:

  • Light, soft components to facilitate natural gait pattern –
    The non-rigid device is designed to allow free movement as opposed to a dictated gait pattern.
  • Real-time analytics for enhanced session control and recording key metrics
    Information and adjustability in the therapist’s hands allow them to optimize the session, and track and report a patient’s progress.
  • Coordinated Plantar/Dorsi flexion assistance
    ReStore is the only device that provides both powered dorsiflexion to address foot drop and plantarflexion to assist with push-off during forward propulsion.

 

When will it be available?

The ReStore exo-suit is currently in clinical study at top U.S. rehabilitation hospitals. ReWalk plans to submit the device for regulatory clearance in 2018 with the goal of commercialization to rehabilitation clinics in the first half of 2019.

Click here to watch the Fox Business News video.

Click here to contact us for more information about ReStore.

Click here for more information on the multi-center clinical trial.

Share this

If you click on one of the icons listed here, your personal data will be transmitted to the selected network.